Evidence map›Paper›PMID 35718642›Full record

ReviewTrends in parasitology2022

Toxoplasma metabolic flexibility in different growth conditions.

Daniel Walsh, Nicholas J Katris, Lilach Sheiner, Cyrille Y Botté

Open access · hybridAbstract readReview
In one paragraph

Review in Trends in parasitology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. The live attenuatedResearch square · 2026
    Article
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Myricetin InhibitsCells · 2026
    Article
  7. Review
  8. Article
  9. Frontiers in cellular and infection microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The apicoplast is important for the viability and persistence ofProceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Daniel WalshWellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow, UK.
Nicholas J KatrisApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.
Lilach SheinerWellcome Centre for Integrative Parasitology, University of Glasgow, Glasgow, UK. Electronic address: Lilach.Sheiner@glasgow.ac.uk.
Cyrille Y BottéApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France. Electronic address: cyrille.botte@univ-grenoble-alpes.fr.
Centre National de la Recherche Scientifique · FRWellcome Centre for Molecular Parasitology · GB

Funding

Medical Research Council MR/S024573/1Wellcome TrustWellcome Trust 217173/Z/19/Z
6 · The paper itself

Abstract

Apicomplexan parasites have complex metabolic networks that coordinate acquisition of metabolites by de novo synthesis and by scavenging from the host. Toxoplasma gondii has a wide host range and may rely on the flexibility of this metabolic network. Currently, the literature categorizes genes as essential or dispensable according to their dispensability for parasite survival under nutrient-replete in vitro conditions. However, recent studies revealed correlations between medium composition and gene essentiality. Therefore, nutrient availability in the host environment likely determines the requirement of metabolic pathways, which may redefine priorities for drug target identification in a clinical setting. Here we review the recent work characterizing some of the major Toxoplasma metabolic pathways and their functional adaptation to host nutrient content.

Indexed as

ToxoplasmaMetabolic Networks and PathwaysProtozoan ProteinsProtozoan ProteinsApicomplexahost–parasite metabolic interactionslipidsmetabolic adaptationmetabolismToxoplasma gondii

Identifiers

PMID35718642
PMCPMC10506913
OpenAlexW4283014853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.